CLINICAL_TRIALS
trial_result
· 2021-02-16
Clinical Trial Update: Dapagliflozin Effects on Epicardial Fat [Phase 4]
Summary
A Phase 4 trial evaluating the effects of dapagliflozin on epicardial fat in adults with type 2 diabetes has completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Miami | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2021-02-16